Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Exagen Inc (NQ: XGN )

2.350 -0.070 (-2.89%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 22, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,108
Open 2.400
Bid (Size) 0.9420 (1)
Ask (Size) 3.200 (1)
Prev. Close 2.420
Today's Range 2.305 - 2.400
52wk Range 2.038 - 4.200
Shares Outstanding 16,126,784
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Exagen Inc. to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference
From Exagen Inc.
Via GlobeNewswire

Performance

YTD
-4.47%
-4.47%
1 Month
-9.00%
-9.00%
3 Month
-24.44%
-24.44%
6 Month
+5.38%
+5.38%
1 Year
-34.54%
-34.54%

More News

Read More
Exagen Inc. Reports Strong Second Quarter 2023 Results
From Exagen Inc.
Via GlobeNewswire
Exagen's Earnings Outlook
Via Benzinga
Exagen: Q1 Earnings Insights
Via Benzinga
Recap: Exagen Q1 Earnings
Via Benzinga
BTIG Maintains Buy Rating for Exagen: Here's What You Need To Know
Via Benzinga
Exagen Earnings Perspective: Return On Capital Employed
Via Benzinga
Exagen Inc. to Participate in the Canaccord Genuity 43rd Annual Growth Conference
From Exagen Inc.
Via GlobeNewswire
Exagen to Announce Second Quarter 2023 Financial Results on August 7, 2023
From Exagen Inc.
Via GlobeNewswire
Exagen Inc. Appoints Paul Kim to Board of Directors
From Exagen Inc.
Via GlobeNewswire
Exagen Inc. to Participate in the William Blair 43rd Annual Growth Stock Conference
From Exagen Inc.
Via GlobeNewswire
Exagen Earnings Preview
Via Benzinga
Exagen Inc. Reports First Quarter 2023 Results
From Exagen Inc.
Via GlobeNewswire
Earnings Scheduled For May 15, 2023
Via Benzinga
Exagen Announces Campaign for Lupus Awareness Month
From Exagen Inc.
Via GlobeNewswire
Exagen to Announce First Quarter 2023 Financial Results on May 15, 2023
From Exagen Inc.
Via GlobeNewswire
Nike, Tencent Music Entertainment And 3 Stocks To Watch Heading Into Tuesday
Via Benzinga
Exagen Inc. Reports Fourth Quarter and Full Year 2022 Results
From Exagen Inc.
Via GlobeNewswire
Exagen to Announce Fourth Quarter and Full Year Financial Results on March 20, 2023
From Exagen Inc.
Via GlobeNewswire
Exagen Inc. to Participate in Upcoming March Conferences
From Exagen Inc.
Via GlobeNewswire
Coya Therapeutics' Expansion Of Exclusive Worldwide Licensing Agreement With ARscience Biotherapeutics Could Have Outsized Impact On Neurodegenerative And Autoimmune Diseases Treatments
Via Benzinga
Exagen Inc. to Participate in the 2023 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
From Exagen Inc.
Via GlobeNewswire
Exagen Inc. Elects Tina S. Nova, Ph.D. as Executive Chair of the Board of Directors
From Exagen Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.